KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Debt Ratio (2016 - 2025)

Travere Therapeutics' Debt Ratio history spans 13 years, with the latest figure at 0.12 for Q2 2025.

  • For Q2 2025, Debt Ratio changed N/A year-over-year to 0.12; the TTM value through Jun 2025 reached 0.12, changed N/A, while the annual FY2024 figure was 0.12, N/A changed from the prior year.
  • Debt Ratio reached 0.12 in Q2 2025 per TVTX's latest filing, down from 0.13 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.14 in Q3 2024 to a low of 0.01 in Q1 2023.
  • Average Debt Ratio over 5 years is 0.05, with a median of 0.01 recorded in 2022.
  • Peak YoY movement for Debt Ratio: plummeted 66.74% in 2021, then rose 9.23% in 2022.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2021, then rose by 9.23% to 0.01 in 2022, then dropped by 9.97% to 0.01 in 2023, then surged by 1133.73% to 0.12 in 2024, then increased by 7.24% to 0.12 in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Debt Ratio are 0.12 (Q2 2025), 0.13 (Q1 2025), and 0.12 (Q4 2024).